In studies comparing the oncogene mutations and biomarker immune expression among Chines, Japanese and Western patients, results have shown that a gene component to pancreatic cancer might be different between Asian and Western pancreatic cancer; Asian patients with pancreatic cancer have different expressions of KRAS and p53 than Western patients (58, 59). This evidence concerns the gene TP53 and pancreatic neoplasm.